crbp: the income statement

MyFinsight

Corbus Pharmaceuticals Holdings, Inc. (CRBP)

For the quarter ending 2025-06-30, CRBP made $1,490K in revenue. -$17,662K in net income. Net profit margin of -1185.37%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

	2025-06-30
Research and development	15,187
General and administrative	3,965
Total operating expenses	19,152
Operating loss	-19,152
Other income, net	176
Interest and investment income, net	1,314
Interest expense	-
Total other income, net	1,490
Net loss	-17,662

Earnings per share, basic, total	-1.44
Earnings per share, diluted	-1.44
Weighted average number of shares outstanding, basic	12,240,443
Weighted average number of shares outstanding, diluted	12,240,443

Unit: Thousand (K) dollars (except for numbers of shares and EPS)